Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.30

TBPH Q4 2015 Earnings — Theravance Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

TBPHTheravance Biopharma, Inc.

$700M

Q4 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M

Gross Profit

$692,00017.8% margin

Operating Income

-$56M-1432.7% margin

Net Income

-$45M-1151.5% margin

EPS (Diluted)

$-1.17

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$34M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$300M

Total Liabilities

$57M

Stockholders' Equity

$243M

Cash & Equivalents

$113M

← FY 2015 All Quarters Q1 2016 →